Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shimeng Liu

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Frontiers in Pharmacology|January 10, 2022
What Is Valued Most by Patients With Type 2 Diabetes Mellitus When Selecting Second-Line Antihyperglycemic Medications in ChinaShimeng Liu, Jing Liu, Yijiang Yu, et al.
Neurological Research|March 31, 2015
Enhanced beneficial effects of mild hypothermia by phenothiazine drugs in stroke therapyShimeng Liu, Xiaokun Geng, Brian Forreider, et al.
Frontiers in Public Health|November 11, 2024
Eliciting medication preferences of patients with type 2 diabetes under different insurance coverages in ChinaLvyun Zheng, Shimeng Liu, Zhigang Liu, et al.
JMIR Public Health and Surveillance|March 13, 2024
Authors' Reply: "The Need for a Bleed Type-Specific Annual Bleeding Rate in Hemophilia Studies"Limin Wang, Shimeng Liu, Shan Jiang, et al.
Mikrochimica Acta|March 20, 2019
Colorimetric determination of lead(II) or mercury(II) based on target induced switching of the enzyme-like activity of metallothionein-stabilized copper nanoclustersRan Liu, Li Zuo, Xiaorong Huang, et al.
Ecotoxicology and Environmental Safety|June 9, 2019
Small interfering RNA targeting of peroxiredoxinⅡ gene enhances formaldehyde-induced toxicity in bone marrow cells isolated from BALB/c miceGuangyan Yu, Yixin Zhang, Shimeng Liu, et al.
Patient Preference and Adherence|September 4, 2024
Comparing the Self-Reported Acceptability of Discrete Choice Experiment and Best-Worst Scaling: An Empirical Study in Patients with Type 2 Diabetes MellitusFuming Li, Shimeng Liu, Yuanyuan Gu, et al.
Integrative Medicine Research|October 23, 2025
The impact of shared decision-making on patient-reported outcomes in Traditional Chinese Medicine in Shanghai, China: a cross-sectional study using structural equation modelingFuming Li, Shimeng Liu, Yue Teng, et al.
Global Health Research and Policy|January 16, 2024
Mapping of health technology assessment in China: a comparative study between 2016 and 2021Shimeng Liu, Yu Xia, Yi Yang, et al.
BMJ Public Health|June 12, 2026
Is best-worst scaling suitable for patient preference elicitation? A nationwide representative comparison with discrete choice experiments among patients with type 2 diabetes in ChinaShimeng Liu, Yingyao Chen, Ying Tao, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Frontiers in Pharmacology|January 10, 2022
What Is Valued Most by Patients With Type 2 Diabetes Mellitus When Selecting Second-Line Antihyperglycemic Medications in ChinaShimeng Liu, Jing Liu, Yijiang Yu, et al.
Neurological Research|March 31, 2015
Enhanced beneficial effects of mild hypothermia by phenothiazine drugs in stroke therapyShimeng Liu, Xiaokun Geng, Brian Forreider, et al.
Frontiers in Public Health|November 11, 2024
Eliciting medication preferences of patients with type 2 diabetes under different insurance coverages in ChinaLvyun Zheng, Shimeng Liu, Zhigang Liu, et al.
JMIR Public Health and Surveillance|March 13, 2024
Authors' Reply: "The Need for a Bleed Type-Specific Annual Bleeding Rate in Hemophilia Studies"Limin Wang, Shimeng Liu, Shan Jiang, et al.
Mikrochimica Acta|March 20, 2019
Colorimetric determination of lead(II) or mercury(II) based on target induced switching of the enzyme-like activity of metallothionein-stabilized copper nanoclustersRan Liu, Li Zuo, Xiaorong Huang, et al.
Ecotoxicology and Environmental Safety|June 9, 2019
Small interfering RNA targeting of peroxiredoxinⅡ gene enhances formaldehyde-induced toxicity in bone marrow cells isolated from BALB/c miceGuangyan Yu, Yixin Zhang, Shimeng Liu, et al.
Patient Preference and Adherence|September 4, 2024
Comparing the Self-Reported Acceptability of Discrete Choice Experiment and Best-Worst Scaling: An Empirical Study in Patients with Type 2 Diabetes MellitusFuming Li, Shimeng Liu, Yuanyuan Gu, et al.
Integrative Medicine Research|October 23, 2025
The impact of shared decision-making on patient-reported outcomes in Traditional Chinese Medicine in Shanghai, China: a cross-sectional study using structural equation modelingFuming Li, Shimeng Liu, Yue Teng, et al.
Global Health Research and Policy|January 16, 2024
Mapping of health technology assessment in China: a comparative study between 2016 and 2021Shimeng Liu, Yu Xia, Yi Yang, et al.
BMJ Public Health|June 12, 2026
Is best-worst scaling suitable for patient preference elicitation? A nationwide representative comparison with discrete choice experiments among patients with type 2 diabetes in ChinaShimeng Liu, Yingyao Chen, Ying Tao, et al.
Pageof 10